A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870

Condition:   Epilepsy Interventions:   Drug: OPC-214870;   Other: Placebo Sponsor:   Otsuka Pharmaceutical Development& Commercialization, Inc. Not yet recruiting

Source: ClinicalTrials.gov - January 27, 2020 Category: Research Source Type: clinical trials